Patents by Inventor Hong Xie
Hong Xie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11979228Abstract: Embodiments of this application provide a signal transmission method and a communications apparatus. The method includes: a terminal device receives information from a network device, wherein the information indicates the terminal device to send a signal in a fallback transmission mode; the terminal device determines that transmission of the signal is failed; and then sends the signal to the network device in the fallback transmission mode.Type: GrantFiled: March 26, 2021Date of Patent: May 7, 2024Assignee: Huawei Technologies Co., Ltd.Inventors: Wenping Bi, Yue Zhao, Hong Wang, Xinqian Xie, Zheng Yu, Xingqing Cheng, Xiang Mi
-
Patent number: 11973700Abstract: A network switch includes a plurality of ports for communicating over a network. Processing circuitry processes inbound frames received from the network via the ports and sends outbound frames to the network. Remote management circuitry (RMU) is responsive to commands received from a host device external to the network switch. The RMU receives via one of the ports a remote access request frame from the host device, wherein at least part of the remote access request frame is encrypted, and decrypts the remote access request frame. In response to successful decryption of the part of the remote access request frame, the RMU accesses one or more configuration registers of the network switch in accordance with the remote access request frame, composes a remote access response frame, at least a portion of the remote access response frame being encrypted, and sends the remote access response frame to the host device.Type: GrantFiled: September 9, 2021Date of Patent: April 30, 2024Assignee: MARVELL ASIA PTE LTDInventors: Chuanhai Zhou, Lian Xie, Hong Yu Chou
-
Method for recycling urea-formaldehyde (UF) and raw materials from wood-based panel, and use thereof
Patent number: 11958942Abstract: The present disclosure provides a method for recycling urea-formaldehyde (UF) from a wood-based panel. In the present disclosure, the UF is depolymerized by an ultrasonic treatment, and depolymerized UF can be reused for UF manufacture and wood-based panel production. The recycled and treated UF can be repeatedly used in wood-based panel manufacture without affecting performances of the wood-based panel. UF-glued wood-based panels can be recycled, and a recycled wood-based panel raw material can replace at least 50% of a non-recycled wood-based raw material for particle board production without affecting performances of the wood-based panel.Type: GrantFiled: April 10, 2023Date of Patent: April 16, 2024Assignee: Southwest Forestry UniversityInventors: Hui Wan, An Mao, Hong Lei, Xiaojian Zhou, Zhi Li, Long Yang, Linkun Xie, Guanben Du -
Publication number: 20240103097Abstract: The present disclosure provides a direct current (DC) transformer error detection apparatus for a pulsating harmonic signal, including a DC and pulsating harmonic current output module and an external detected input module, where the DC and pulsating harmonic current output module outputs a DC and a DC superimposed pulsating harmonic current to an internal sampling circuit and a self-calibrated standard resistor array; and the internal sampling circuit converts the input DC and the input DC superimposed pulsating harmonic current into a voltage signal, and sends the voltage signal to an analog-to-digital (AD) sampling and measurement component through a front-end conditioning circuit and a detected input channel. The DC transformer error detection apparatus can complete self-calibration for measurement of the DC and the pulsating harmonic signal on a test site.Type: ApplicationFiled: August 17, 2022Publication date: March 28, 2024Inventors: Xin Zheng, Wenjing Yu, Tao Peng, Yi Fang, Ming Lei, Hong Shi, Ben Ma, Li Ding, Wei Wei, Linghua Li, He Yu, Tian Xia, Yingchun Wang, Sike Wang, Dongri Xie, Xin Wang, Bo Pang, Xianjin Rong
-
Patent number: 11926742Abstract: A method for preparing carbon black from pyrolysis char of waste tires by a molten salt thermal treatment and a product thereof are provided. The method includes heating one or two groups of a metal chloride salt group and a metal sulfate group to obtain a molten salt; adding pyrolysis char of waste tires into the molten salt and subjecting same to a molten salt thermal treatment under a preset reaction atmosphere; after the reaction is complete, separating the reaction product to obtain a secondary molten salt and treated pyrolysis char, washing the treated pyrolysis char with hot water and then drying same so as to obtain carbon black, and at the same time, recycling the secondary molten salt.Type: GrantFiled: May 15, 2020Date of Patent: March 12, 2024Assignee: HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Hongyun Hu, Hua Tang, Aijun Li, Kang Xie, Yuhan Yang, Fu Yang, Hong Yao
-
Publication number: 20240003954Abstract: A long-distance high-voltage cable fault degree detection method. A cable fault positioning curve is obtained by using a frequency-domain reflection method, and a cable fault positioning compensation curve is determined by means of theoretical calculation in combination with the parameters of a frequency-domain incident signal, cable structure parameters, and characteristic parameters of each layer of materials of the field test; furthermore, a cable fault diagnosis curve is determined on the basis of the cable fault positioning curve and the cable fault positioning compensation curve, the severity of the fault is determined by means of the amplitude of a peak point of the cable fault diagnosis curve, and the accuracy of long-distance high-voltage cable fault degree diagnosis is effectively improved.Type: ApplicationFiled: October 21, 2021Publication date: January 4, 2024Applicants: ELECTRIC PWR RESEARCH INST. CHINA SOUTH PWR GRID, SHENZHEN POWER SUPPLY CO., LTDInventors: Shuai HOU, Mingli FU, Xiaolin LI, Wenbo ZHU, Baojun HUI, Bin FENG, Yifan ZHANG, Guoxing WU, Hong XIE, Shu XU, Xiao CHEN, Lu CHEN, Lu ZHAI
-
Publication number: 20230390392Abstract: Several embodiments of the methods and compositions disclosed herein relate to immune cells that are engineered to express chimeric antigen receptors (CAR) and/or genetically modified to reduce potential side effects of cellular immunotherapy. Several embodiments relate to genetic modifications to the immune cells, such as Natural Killer (NK) cells, to reduce, substantially, reduce, or eliminate expression of a combination of genes and their corresponding proteins. In several embodiments, one edit is to reduce expression of a marker by the immune cells that would otherwise cause them to be self-targeted by the CAR and at least two additional gene edits to enhance the cytotoxicity and/or persistence of the resulting cells. In several embodiments, the CAR targets CD70, and in some embodiments is used for renal cell carcinoma immunotherapy.Type: ApplicationFiled: March 6, 2023Publication date: December 7, 2023Inventors: James Barnaby Trager, Ivan Chan, Chao Guo, Luxuan Guo Buren, Alexandra Leida Liana Lazetic, Mary-Lee Dequéant, Hanspeter Waldner, Changan Guo, Chandirasegaran Massilamany, Ming-Hong Xie, Elizabeth N. Koch, Jacob Usadi, Parin Sripakdeevong
-
Patent number: 11827751Abstract: A nanonetwork with controlled chirality prepared via self-assembly of triblock terpolymers, wherein each of the triblock terpolymers includes a first block, a second block and a third block. The first block is connected to the second block, and the third block is connected to the second block. The first block, the second block and the third block are incompatible. The third block has a homochiral characteristic, and a chirality of the nanonetwork with controlled chirality is determined by the homochiral characteristic.Type: GrantFiled: October 14, 2021Date of Patent: November 28, 2023Assignee: NATIONAL TSING HUA UNIVERSITYInventors: Hsiao-Fang Wang, Po-Ting Chiu, Chih-Ying Yang, Zhi-Hong Xie, Yu-Chueh Hung, Jing-Yu Lee, Jing-Cherng Tsai, Ishan Prasad, Hiroshi Jinnai, Edwin L. Thomas, Rong-Ming Ho
-
Publication number: 20230272469Abstract: An example of a method includes providing a substrate with an exposed surface comprising a first chemical group, wherein the providing optionally comprises modifying the exposed surface of the substrate to incorporate the first chemical group; reacting the first chemical group with a first reactive group of a functionalized polymer molecule to form a functionalized polymer coating layer covalently bound to the exposed surface of the substrate; grafting a primer to the functionalized polymer coating layer by reacting the primer with a second reactive group of the functionalized polymer coating layer; and forming a water-soluble protective coating on the primer and the functionalized polymer coating layer. Examples of flow cells incorporating examples of the water-soluble protective coating are also disclosed herein.Type: ApplicationFiled: May 9, 2023Publication date: August 31, 2023Inventors: Sean M. Ramirez, Brian D. Mather, Edwin Li, Sojeong Moon, Innsu Daniel Kim, Alexandre Richez, Ludovic Vincent, Xavier von Hatten, Hai Quang Tran, Maxwell Zimmerley, Julia Morrison, Gianluca Andrea Artioli, Krystal Sly, Hayden Black, Lewis J. Kraft, Hong Xie, Wei Wei, Ryan Sanford
-
Publication number: 20230241087Abstract: The present disclosure provides methods for treating a human patient diagnosed with a cancer, comprising administering a therapeutically effective amount of a PR.MTS (protein arginine methyltransferase 5) inhibitor, certain methods comprising (i) administering to the patient initial doses of at least about 0.1 mg per day of the PRMT5 inhibitor that is (1S,2R,3 S,SR)-3-(2-(2-amino-3-bromoquinolin-7-yl)ethyl)-5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol or a pharmaceutically acceptable addition salt or solvate thereof for an initial dosing period of about 5 to about 20 days; and (ii) administering to the patient subsequent doses of at least about 0.1 mg per day of the PRMT5 inhibitor for one or more subsequent dosing periods of about 5 to about 20 days each. In these methods, a first subsequent dosing period is separated in time from the initial dosing period by at least about 5 days and the subsequent dosing periods are separated in time from each other by at least about 5 days.Type: ApplicationFiled: January 26, 2023Publication date: August 3, 2023Inventors: Hillary Joy Millar Quinn, Kathryn Elizabeth Packman, Nahor Haddish-Berhane, Geert S.J. Mannens, Junguo Zhou, Anthony T. Greway, Dirk Brehmer, Yue Guo, Tongfei Wu, Hong Xie, Josh Lauring
-
Patent number: 11680907Abstract: Systems and methods for characterizing biological specimens, which may involve identifying a cell type or state corresponding to a disease or health condition of a subject. A biological specimen is subjected to electromagnetic radiation for spectroscopic analysis such as Surface Enhanced Raman Spectroscopy (SERS) to determine the relative abundance of proteins or amino acids in the cells, which is used in a comparison to previously stored relative abundance data of a database to automatically identifies at least one of cell type and/or cell state of the cells (or the disease/health state of the subject with the disease state including the possibility of virus infection, or drug susceptibility of a subject to bacteria or fungus). The method may also be employed with biological entities or cellular structures such as exosomes and even protein or nucleic acid fragments to determine disease states or health states of the subject.Type: GrantFiled: August 26, 2022Date of Patent: June 20, 2023Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Ya-Hong Xie, Owen Liang
-
Patent number: 11667969Abstract: An example of a method includes providing a substrate with an exposed surface comprising a first chemical group, wherein the providing optionally comprises modifying the exposed surface of the substrate to incorporate the first chemical group; reacting the first chemical group with a first reactive group of a functionalized polymer molecule to form a functionalized polymer coating layer covalently bound to the exposed surface of the substrate; grafting a primer to the functionalized polymer coating layer by reacting the primer with a second reactive group of the functionalized polymer coating layer; and forming a water-soluble protective coating on the primer and the functionalized polymer coating layer. Examples of flow cells incorporating examples of the water-soluble protective coating are also disclosed herein.Type: GrantFiled: May 2, 2018Date of Patent: June 6, 2023Assignees: Illumina, Inc., Illumina Cambridge Limited, Illumina Singapore Pte. Ltd.Inventors: Sean M. Ramirez, Brian D. Mather, Edwin Li, Sojeong Moon, Innsu Daniel Kim, Alexandre Richez, Ludovic Vincent, Xavier von Hatten, Hai Quang Tran, Maxwell Zimmerley, Julia Morrison, Gianluca Andrea Artioli, Krystal Sly, Hayden Black, Lewis J. Kraft, Hong Xie, Wei Wei, Ryan Sanford
-
Publication number: 20230134077Abstract: A method for detecting a storage life of a pre-crosslinked material is provided. Tableting is performed on an unaged pre-crosslinked material to obtain crosslinked polyethylene. A crosslinking degree and a mechanical property of the crosslinked polyethylene are measured to obtain reference data. The pre-crosslinked material is heated to obtain a fast-aged pre-crosslinked material. The crosslinking degree and mechanical property of crosslinked polyethylene obtained from the fast-aged pre-crosslinked material are measured to obtain measurement results, which are compared with the reference data. If comparison results all fall within corresponding ranges, the time period of heating is increased by a step to repeat the above steps until the comparison results do not all fall within the corresponding ranges. A result obtained by subtracting the step from the time period of heating is converted into a time period of storage at the room temperature.Type: ApplicationFiled: October 21, 2021Publication date: May 4, 2023Applicants: ELECTRIC POWER RESEARCH INSTITUTE. CHINA SOUTHERN POWER GRID, SHENZHEN POWER SUPPLY CO., LTD.Inventors: Xiaolin LI, Mingli FU, Shuai HOU, Baojun HUI, Wenbo ZHU, Guoxing WU, Hong XIE, Xiao CHEN, Shu XU, Bin FENG, Yifan ZHANG
-
Patent number: 11597689Abstract: A process and system for the conversion of a feedstock comprising C3-C5 light alkanes to a C5+ hydrocarbon product, for example, a BTX-rich hydrocarbon product, by performing the alkane activation (first-stage) and the oligomerization/aromatization (second-stage) in separate stages, which allows each conversion process to occur at optimal reaction conditions thus increasing the overall hydrocarbon product yield. The alkane activation or first-stage is operated at a higher temperature than the second-stage since light alkanes are much less reactive than light olefins. Since aromatization of olefins is more efficient at higher pressure, the second-stage is maintained at a higher pressure than the first-stage. Further, fixed-bed catalysts are used in each of the first-stage and the second-stage.Type: GrantFiled: October 21, 2020Date of Patent: March 7, 2023Assignee: Phillips 66 CompanyInventors: Jianhua Yao, Hong Xie, Jonathan Marda, Dhananjay Ghonasgi, Sourabh Pansare
-
Patent number: 11591395Abstract: Bispecific monoclonal antibodies and methods for treating cancer are set forth herein.Type: GrantFiled: April 17, 2020Date of Patent: February 28, 2023Assignee: JANSSEN BIOTECH, INC.Inventors: Theresa McDevitt, Shoba Shetty, Hong Xie
-
Patent number: 11571437Abstract: The present disclosure provides methods for treating a human patient diagnosed with a cancer, comprising administering a therapeutically effective amount of a PRMT5 (protein arginine methyltransferase 5) inhibitor, certain methods comprising (i) administering to the patient initial doses of at least about 0.1 mg per day of the PRMT5 inhibitor that is (1S,2R,3S,5R)-3-(2-(2-amino-3-bromoquinolin-7-yl)ethyl)-5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol or a pharmaceutically acceptable addition salt or solvate thereof for an initial dosing period of about 5 to about 21 days; and (ii) administering to the patient subsequent doses of at least about 0.1 mg per day of the PRMT5 inhibitor for one or more subsequent dosing periods of about 5 to about 21 days each. In these methods, a first subsequent dosing period is separated in time from the initial dosing period by at least about 5 days and the subsequent dosing periods are separated in time from each other by at least about 5 days.Type: GrantFiled: June 5, 2020Date of Patent: February 7, 2023Assignee: Janssen Pharmaceutica NVInventors: Hillary Joy Millar Quinn, Kathryn Elizabeth Packman, Nahor Haddish-Berhane, Geert S. J. Mannens, Junguo Zhou, Anthony T. Greway, Dirk Brehmer, Yue Guo, Tongfei Wu, Hong Xie, Josh Lauring
-
Publication number: 20220411590Abstract: A nanonetwork with controlled chirality prepared via self-assembly of triblock terpolymers, wherein each of the triblock terpolymers includes a first block, a second block and a third block. The first block is connected to the second block, and the third block is connected to the second block. The first block, the second block and the third block are incompatible. The third block has a homochiral characteristic, and a chirality of the nanonetwork with controlled chirality is determined by the homochiral characteristic.Type: ApplicationFiled: October 14, 2021Publication date: December 29, 2022Inventors: Hsiao-Fang WANG, Po-Ting CHIU, Chih-Ying YANG, Zhi-Hong XIE, Yu-Chueh HUNG, Jing-Yu LEE, Jing-Cherng TSAI, Ishan PRASAD, Hiroshi JINNAI, Edwin L. THOMAS, Rong-Ming HO
-
Publication number: 20220412892Abstract: Systems and methods for characterizing biological specimens, which may involve identifying a cell type or state corresponding to a disease or health condition of a subject. A biological specimen is subjected to electromagnetic radiation for spectroscopic analysis such as Surface Enhanced Raman Spectroscopy (SERS) to determine the relative abundance of proteins or amino acids in the cells, which is used in a comparison to previously stored relative abundance data of a database to automatically identifies at least one of cell type and/or cell state of the cells (or the disease/health state of the subject with the disease state including the possibility of virus infection, or drug susceptibility of a subject to bacteria or fungus). The method may also be employed with biological entities or cellular structures such as exosomes and even protein or nucleic acid fragments to determine disease states or health states of the subject.Type: ApplicationFiled: August 26, 2022Publication date: December 29, 2022Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Ya-Hong Xie, Owen Liang
-
Patent number: 11525862Abstract: A method for calculating a short-circuit current of a battery. includes: obtaining an integral state of charge and a current state of charge of the battery; calculating a first difference based on the integral state of charge and the current state of charge; calculating the short-circuit current of the battery based on the first difference; obtaining a first real state of charge and a second real state of charge; updating the first real state of charge and the second real state of charge based on a temperature-impedance table and the short-circuit current of the battery; calculating a second difference based on the updated first real state of charge and the updated second real state of charge; and updating the short-circuit current of the battery based on the second difference.Type: GrantFiled: April 8, 2020Date of Patent: December 13, 2022Assignee: NINGDE AMPEREX TECHNOLOGY LIMITEDInventors: Hong Xie, Xuefeng Liu, Guanghui Chen
-
Patent number: D1018944Type: GrantFiled: November 14, 2022Date of Patent: March 19, 2024Assignee: shenzhen Homi Lighting Co., ltdInventors: Hong Li, Peizhu Xie, Shengcheng Zhang